Latest Nureca stock price

Nureca P/E Ratio

NURECA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
26.72
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 26.72
Current Price ₹282.25
EPS (TTM) ₹0.85
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 19.48
Historical Range 12.68 - 26.28
Percentile 100.0%

Sector Context

Sector Average 48.24
Sector Median 27.37
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹10.82
Sept 2025 ₹3.63
Mar 2025 ₹2.47

Key P/E Ratio Insights for Nureca

  • Stock appears overvalued with PE of 26.72, suggesting caution for new investments
  • Current PE is 37.2% above historical average
  • Trading at discount to sector average PE of 48.24

View the NURECA equity price for detailed stock performance.

P/E Ratio Historical Trend for Nureca

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 26.28 10.82 ₹284.30 NSE High
2021 12.68 50.92 ₹645.75 NSE Low

Sector P/E Ratio Comparison

Comparing Nureca with other companies in Healthcare sector
Sector Average
48.24
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low